Neuraxis director granted 21,598 shares at $4.63

Neuraxis, Inc. director Kristin A. Ferge received 21,598 shares of common stock on January 22, 2026, reported as an "A" (acquired) transaction.

Accepted by SEC EDGAR 01/30/2026 - 06:30 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Neuraxis, Inc. director Kristin A. Ferge received 21,598 shares of common stock on January 22, 2026, reported as an "A" (acquired) transaction. The shares were issued at $4.63 per share as compensation for her services as an independent director. Following this grant, she directly owns 35,938 shares of Neuraxis common stock.

Insider Trade Summary

Grant/Award: 21,598 shares

Grant/Award 1 txn

Insider Ferge Kristin A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	21,598	$4.63	$100K

Holdings After Transaction: Common Stock — 35,938 shares (Direct)

Footnotes (1)

F1. These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Neuraxis (NRXS) report for Kristin A. Ferge?

Neuraxis reported that director Kristin A. Ferge acquired 21,598 shares of common stock. The acquisition occurred on January 22, 2026 and was reported as an "A" code transaction, meaning shares were awarded rather than bought in the open market.

At what price were Kristin A. Ferge’s Neuraxis (NRXS) shares recorded?

The 21,598 Neuraxis shares for Kristin A. Ferge were recorded at a price of $4.63 per share. This figure reflects the value used for reporting purposes when the shares were issued as compensation for her independent director services.

How many Neuraxis (NRXS) shares does Kristin A. Ferge own after this Form 4?

After the reported transaction, Kristin A. Ferge beneficially owns 35,938 shares of Neuraxis common stock. These shares are listed as held directly, reflecting her total reported ownership following the January 22, 2026 stock compensation grant.

Why did Kristin A. Ferge receive Neuraxis (NRXS) shares in this filing?

The filing explains that the 21,598 Neuraxis shares were issued to Kristin A. Ferge as compensation. They were granted for her services as an independent director of the company, rather than being purchased in the market for cash consideration.

What does transaction code "A" mean in the Neuraxis (NRXS) Form 4?

In this Neuraxis Form 4, transaction code "A" indicates an acquisition of securities. Here, it represents a stock grant, where Kristin A. Ferge received common shares as compensation for her board service instead of executing a regular market purchase.

Is Kristin A. Ferge’s Neuraxis (NRXS) ownership direct or indirect?

The Form 4 lists Kristin A. Ferge’s Neuraxis holdings as directly owned. After receiving 21,598 shares as compensation, her total of 35,938 common shares is reported with ownership type "D," indicating direct beneficial ownership rather than through an intermediary entity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ferge Kristin A

(Last)

(First)

(Middle)

11611 N. MERIDIAN ST, SUITE 330

(Street)

CARMEL

46032

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Neuraxis, INC [ NRXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/22/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	01/22/2026		A		21,598	A	$4.63⁽¹⁾	35,938	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer.

	/s/ Kristin Ferge	01/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR